Opinion: It’s well past time for Catholic hospitals to be secularized - The Globe and Mail

The Thunder Bay catholic district school board has announced a new collaboration aimed at improving student physical health and social connection. VIDEO: Thunder Bay public library workers begin strike action

Catholic institutions and leaders gather in Rome under the patronage of the Pontifical Academy for Life to strengthen the Church’s ministry to people experiencing mental health difficulties and address stigma and discrimination. Bishops, pastoral workers, mental health professionals and people with lived experience of mental illness will gather in Rome on 9–10 October for “A Healing Presence: The Church’s Call to Mental Health Ministry.” The meeting coincides with World Mental Health Day and Pope Leo XIV’s October prayer intention, which calls for mental health ministry to be established throughout the Church and for stigma and discrimination against people with mental illnesses to be overcome.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.